An official website of the United States government
Regenerative Medicine Innovation Project (RMIP)
The Regenerative Medicine Innovation Project (RMIP) was established by the 21st Century Cures Act to accelerate progress in the field by supporting clinical research on adult stem cells, while promoting scientific rigor and protecting patient safety. This initiative is a trans-NIH effort, in coordination with the Food and Drug Administration (FDA).
Funding opportunities
Active and archived Regenerative Medicine Innovation Project (RMIP) funding opportunities.
About RMIP
The RMIP is one of four Innovation Projects authorized under the Cures Act; the others are the Precision Medicine Initiative (“All of Us”), the Beau Biden Cancer Moonshot, and the BRAIN Initiative.
The NIH RMIP launched following passage of the 21st Century Cures Act, which authorized $30 million over four years “for clinical research to further the field of regenerative medicine using adult stem cells.”
NIH continues to work in close collaboration with the U.S. Food and Drug Administration to implement the RMIP.